Parkside Financial Bank & Trust’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $428 | Sell |
95
-134
| -59% | -$698 | ﹤0.01% | 2588 |
|
|
2025
Q4 | $1.41K | Hold |
229
| – | – | ﹤0.01% | 2223 |
|
|
2025
Q3 | $1.66K | Buy |
229
+95
| +71% | +$564 | ﹤0.01% | 2089 |
|
|
2025
Q2 | $712 | Buy |
134
+4
| +3% | +$24 | ﹤0.01% | 2374 |
|
|
2025
Q1 | $1.15K | Buy |
130
+33
| +34% | +$396 | ﹤0.01% | 2062 |
|
|
2024
Q4 | $1.33K | Sell |
97
-7
| -7% | -$129 | ﹤0.01% | 1687 |
|
|
2024
Q3 | $2.85K | Hold |
104
| – | – | ﹤0.01% | 1536 |
|
|
2024
Q2 | $2.54K | Hold |
104
| – | – | ﹤0.01% | 1512 |
|
|
2024
Q1 | $2.22K | Buy |
104
+87
| +512% | +$1.87K | ﹤0.01% | 1492 |
|
|
2023
Q4 | $326 | Sell |
17
-405
| -96% | -$7.01K | ﹤0.01% | 1829 |
|
|
2023
Q3 | $6.77K | Sell |
422
-6
| -1% | -$114 | ﹤0.01% | 1254 |
|
|
2023
Q2 | $9.92K | Sell |
428
-1
| -0.2% | -$22 | ﹤0.01% | 1119 |
|
|
2023
Q1 | $9.97K | Buy |
429
+172
| +67% | +$3.49K | ﹤0.01% | 1108 |
|
|
2022
Q4 | $3.73K | Buy |
257
+8
| +3% | +$149 | ﹤0.01% | 1443 |
|
|
2022
Q3 | $5K | Hold |
249
| – | – | ﹤0.01% | 1225 |
|
|
2022
Q2 | $5K | Sell |
249
-16
| -6% | -$332 | ﹤0.01% | 1238 |
|
|
2022
Q1 | $7K | Sell |
265
-90
| -25% | -$2.3K | ﹤0.01% | 1159 |
|
|
2021
Q4 | $10K | Buy |
355
+86
| +32% | +$2.49K | ﹤0.01% | 1033 |
|
|
2021
Q3 | $9K | Buy |
269
+1
| +0.4% | +$33 | ﹤0.01% | 1003 |
|
|
2021
Q2 | $8K | Buy |
268
+19
| +8% | +$549 | ﹤0.01% | 1056 |
|
|
2021
Q1 | $8K | Hold |
249
| – | – | ﹤0.01% | 1018 |
|
|
2020
Q4 | $5K | Buy |
249
+132
| +113% | +$2.13K | ﹤0.01% | 1115 |
|
|
2020
Q3 | $2K | Sell |
117
-8
| -6% | -$101 | ﹤0.01% | 1187 |
|
|
2020
Q2 | $1K | Sell |
125
-78
| -38% | -$1.11K | ﹤0.01% | 1347 |
|
|
2020
Q1 | $3K | Buy |
203
+122
| +151% | +$2.58K | ﹤0.01% | 1017 |
|
|
2019
Q4 | $2K | Buy |
81
+4
| +5% | +$110 | ﹤0.01% | 1205 |
|
|
2019
Q3 | $2K | Buy |
77
+39
| +103% | +$1.14K | ﹤0.01% | 1186 |
|
|
2019
Q2 | $1K | Sell |
38
-55
| -59% | -$1.55K | ﹤0.01% | 1411 |
|
|
2019
Q1 | $3K | Buy |
93
+45
| +94% | +$1.37K | ﹤0.01% | 1082 |
|
|
2018
Q4 | $1K | Hold |
48
| – | – | ﹤0.01% | 1261 |
|
|
2018
Q3 | $2K | Hold |
48
| – | – | ﹤0.01% | 1100 |
|
|
2018
Q2 | $2K | Buy |
48
+38
| +380% | +$1.28K | ﹤0.01% | 1080 |
|
|
2018
Q1 | $0 | Sell |
10
-38
| -79% | -$1.29K | ﹤0.01% | 1508 |
|
|
2017
Q4 | $2K | Hold |
48
| – | – | ﹤0.01% | 995 |
|
|
2017
Q3 | $2K | Hold |
48
| – | – | ﹤0.01% | 991 |
|
|
2017
Q2 | $1K | Sell |
48
-1
| -2% | -$21 | ﹤0.01% | 1191 |
|
|
2017
Q1 | $1K | Buy |
+49
| New | +$868 | ﹤0.01% | 1161 |
|
|
2016
Q1 | – | Sell |
-150
| Closed | -$6K | – | 1081 |
|
|
2015
Q4 | $6K | Hold |
150
| – | – | ﹤0.01% | 746 |
|
|
2015
Q3 | $6K | Buy |
+150
| New | +$5.32K | ﹤0.01% | 754 |
|
Other funds holding MYGN
O
GCM
VCM
VPM
Parkside Financial Bank & Trust's MYGN Position: Q1 2026 in Review
Parkside Financial Bank & Trust reduced its Myriad Genetics (MYGN) stake by 59% in Q1 2026, selling an estimated $698 and leaving 95 shares worth $428. The position accounts for ﹤0.01% of the portfolio, ranked #2588.
Parkside Financial Bank & Trust first reported a position in MYGN in Q3 2015 and has held it in 39 quarters since. The position peaked at $10K in Q4 2021. 202 funds tracked by Wall St. Rank hold MYGN as of Q1 2026.
- Parkside Financial Bank & Trust held 95 shares of Myriad Genetics worth $428 as of Q1 2026.
- Parkside Financial Bank & Trust sold 134 Myriad Genetics shares in Q1 2026, an estimated $698.
- Myriad Genetics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2588 holding.
- Parkside Financial Bank & Trust first reported a position in Myriad Genetics in Q3 2015 and has held it in 39 quarters since.
- Parkside Financial Bank & Trust's Myriad Genetics position peaked at $10K in Q4 2021.
- 202 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.